Online Imaginal Exposure Therapy for Eating Disorders Trial
- Sponsor
- University College, London
- Study ID
- NCT06818695
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Anorexia Nervosa
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Imaginal Exposure for Anorexia Nervosa — OTHERImaginal exposure aims to use the power of imagining the fearful situation to heighten anxiety and by not engaging in imaginative restriction or other eating disorder behaviours, the individual, in theory, can habituate to the anxiety until it naturally subsides.
- Treatment as Usual (TAU) — OTHERTAU includes specialist nurse monitoring, occasional medical reviews, and dietetic support (depending on the individual's particular needs)
Study Details
The goal of this clinical trial is to learn if an imaginal exposure intervention first conducted by Levinson and colleagues (2020) can produce similar promising results in individuals with anorexia on the waiting list of an NHS eating disorder service. The main question it aims to answer is: 1. How effective is Imaginal Exposure Therapy in reducing eating disorder symptoms and increasing weight in patients with AN? The secondary research questions are: 2. How effective is Imaginal Exposure Therapy in reducing anxiety and fear related outcomes around food and eating? 3. How effective is Imaginal Exposure Therapy in improving patients' general anxiety and depression symptoms? Researchers will compare the results of individuals in the treatment condition to individual's in the control condition to explore the efficacy of the intervention on eating disorder and eating disorder fear symptomology, and body weight. Participants in the intervention group will receive 4 sessions of online exposure therapy, and participants in the control group will remain on the waiting list with treatment as usual (primarily nurse monitoring).
Key Dates
- First listed
- Feb 10, 2025
- Start date
- Apr 30, 2025
- Status verified
- Apr 2025
- Primary completion
- Apr 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 76 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment ArmParticipants will receive imaginal exposure for Anorexia Nervosa
- Active Comparator: Waitlist ControlParticipants in this arm will remain on the waitlist for the service and receive treatment as usual (TAU), which includes specialist nurse monitoring, occasional medical reviews, and dietetic support (depending on the individual's particular needs).
Primary Outcome Measure
Eating Disorder Examination Questionnaire [ Time Frame: From initial interview till the end of treatment after 5 weeks ]
Central Contacts
- Amber L Cameron, BA Experimental Psychology+44 7703329648
- Lucy Serpell
Related Studies
- Study of Food Aversion in Patients With Anorexia NervosaRecruiting · University of California, San Diego · La Jolla, California
- Transdermal Estrogen in Women With Anorexia NervosaPHASE2 · Recruiting · Pouneh K. Fazeli, MD · Pittsburgh, Pennsylvania
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Relapse Prevention and Changing Habits in Anorexia NervosaRecruiting · New York State Psychiatric Institute · New York, New York